Actively Recruiting
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Led by Public Health Foundation Enterprises, Inc. · Updated on 2022-09-28
300
Participants Needed
4
Research Sites
105 weeks
Total Duration
On this page
Sponsors
P
Public Health Foundation Enterprises, Inc.
Lead Sponsor
P
Patient-Centered Outcomes Research Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
CONDITIONS
Official Title
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identify as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum)
- Have had sex with a cisgender man, transgender woman, or any individual assigned male sex at birth in the past 12 months
- Be 15 years of age or older
- Be willing and able to provide written informed consent
- Own an iOS or Android mobile phone and be able to access the internet and send and receive text messages
- Be able to understand, read, and speak English or Spanish
- Have newly started PrEP or currently be on PrEP and at risk for stopping it, defined by either starting PrEP within the past 6 months or having risk factors such as missed clinic visits, age under 30, African-American or Latino ethnicity, transgender gender identity, or self-reported illicit substance use
You will not qualify if you...
- Currently enrolled in another PrEP intervention study
- Unable to participate in the study for 12 months
- Have any medical, psychiatric, social condition, or other responsibilities that would make participation unsafe, complicate study results, or interfere with study goals as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Bridge HIV, San Francisco Department of Public Health
San Francisco, California, United States, 94102
Active, Not Recruiting
2
San Francisco AIDS Foundation
San Francisco, California, United States, 94114
Actively Recruiting
3
Whitman-Walker Health
Washington D.C., District of Columbia, United States, 20009
Actively Recruiting
4
University of Miami
Miami, Florida, United States, 33136
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here